Probucol in Albuminuric Type 2 Diabetes Mellitus Patients on Renin–Angiotensin System Blockade | Zendy

SangMan Jin | Zendy; Kyung Ah Han | Zendy; Jae Myung Yu | Zendy; Tae Seo Sohn | Zendy; Sung Hee Choi | Zendy; Choon Hee Chung | Zendy; Ie Byung Park | Zendy; EunJung Rhee | Zendy; Sei Hyun Baik | Zendy; Tae Sun Park | Zendy; In Kyu Lee | Zendy; Seung-Hyun Ko | Zendy; YouCheol Hwang | Zendy; Bong Soo | Zendy; Hyoung Woo Lee | Zendy; Moonsuk Nam | Zendy; MoonKyu Lee | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Probucol in Albuminuric Type 2 Diabetes Mellitus Patients on Renin–Angiotensin System Blockade

Author(s) -

SangMan Jin,

Kyung Ah Han,

Jae Myung Yu,

Tae Seo Sohn,

Sung Hee Choi,

Choon Hee Chung,

Ie Byung Park,

EunJung Rhee,

Sei Hyun Baik,

Tae Sun Park,

In Kyu Lee,

Seung-Hyun Ko,

YouCheol Hwang,

Bong Soo,

Hyoung Woo Lee,

Moonsuk Nam,

MoonKyu Lee

Publication year - 2016

Publication title -

arteriosclerosis thrombosis and vascular biology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.007

H-Index - 270

eISSN - 1524-4636

pISSN - 1079-5642

DOI - 10.1161/atvbaha.116.308034

Subject(s) - probucol , medicine , blockade , renin–angiotensin system , diabetes mellitus , type 2 diabetes mellitus , endocrinology , cardiology , cholesterol , blood pressure , receptor

To determine the effect of probucol on urine albumin excretion in type 2 diabetes mellitus patients with albuminuria using angiotensin-converting enzyme inhibitors or angiotensin receptor blockers.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research